Literature DB >> 3956771

Decreased sensitivity to insulin in women with microprolactinomas.

O Serri, H Beauregard, E Rasio, J Hardy.   

Abstract

To determine whether there exists an altered sensitivity to insulin in hyperprolactinemia, we studied, in 15 women with microprolactinomas, the insulin effects on glucose, PRL, GH, and cortisol before and after successful adenoma removal. Our results show that in women with microprolactinomas, the sensitivity to insulin is lower in hyperprolactinemia than in normoprolactinemia achieved by selective adenomectomy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956771

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.

Authors:  Saptarshi Bhattacharya; Sanjay Kalra; Deep Dutta; Deepak Khandelwal; Rajiv Singla
Journal:  Eur Endocrinol       Date:  2019-10-18

2.  Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Authors:  C D Gibson; W Karmally; D J McMahon; S L Wardlaw; J Korner
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

3.  Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.

Authors:  Serap Soytac Inancli; Alper Usluogullari; Yusuf Ustu; Sedat Caner; Abbas Ali Tam; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-12-12       Impact factor: 3.633

4.  Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?

Authors:  M Bahceci; A Tuzcu; S Bahceci; S Tuzcu
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

5.  Insulin sensitivity and hyperprolactinemia.

Authors:  A Tuzcu; M Bahceci; M Dursun; C Turgut; S Bahceci
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

6.  Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.

Authors:  Alpaslan Tuzcu; Serkan Yalaki; Senay Arikan; Deniz Gokalp; Mithat Bahcec; Sadiye Tuzcu
Journal:  Pituitary       Date:  2009-05-01       Impact factor: 4.107

Review 7.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

8.  Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.

Authors:  Michael Ezrokhi; Shuqin Luo; Yelena Trubitsyna; Anthony H Cincotta
Journal:  Diabetol Metab Syndr       Date:  2014-09-25       Impact factor: 3.320

9.  Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.

Authors:  Michael Ezrokhi; Yahong Zhang; Shuqin Luo; Anthony H Cincotta
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline.

Authors:  Nazir A Pala; Bashir A Laway; Raiz A Misgar; Rayees A Dar
Journal:  Diabetol Metab Syndr       Date:  2015-11-14       Impact factor: 3.320

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.